Medical Research News

RSS

Injections of anaerobic bacteria can shrink tumors in rats, dogs and human

Deep within most tumors lie areas that remain untouched by chemotherapy and radiation. These troublesome spots lack the blood and oxygen needed for traditional therapies to work, but provide the perfect target for a new cancer treatment using bacteria that thrive in oxygen-poor conditions.

14 Aug 2014

Bacteria in critically ill patients may be growing increasingly resistant to common antiseptic

Bacteria that cause life-threatening bloodstream infections in critically ill patients may be growing increasingly resistant to a common hospital antiseptic, according to a recent study led by investigators at Johns Hopkins.

14 Aug 2014

Cancer Research UK funds projects for new cancer study

A NEW funding scheme launched by Cancer Research UK today (Thursday) looks to bring new insight to some of cancer's biggest challenges.

14 Aug 2014

More than ½ of emergency department patients age 65 and older are malnourished

More than half of emergency department patients age 65 and older who were seen at UNC Hospitals during an 8-week period were either malnourished or at risk for malnutrition.

14 Aug 2014

Researchers find that nanopores in material MoS2 could sequence DNA more accurately

Gene-based personalized medicine has many possibilities for diagnosis and targeted therapy, but one big bottleneck: the expensive and time-consuming DNA-sequencing process.

14 Aug 2014

Recurrence of breast cancer cut by ½ in overweight women who regularly use NSAIDs

Recurrence of hormone-related breast cancer was cut by half in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), according to data published in Cancer Research, a journal of the American Association for Cancer Research.

14 Aug 2014

Healthy men participating in Prostate Cancer Prevention Trial are most likely to undergo biopsy

Healthy men participating in the Prostate Cancer Prevention Trial who actively participate in all steps of the clinical trial are most likely to undergo a biopsy, according to a study published in Cancer Epidemiology, Biomarkers and Prevention - a journal of the American Association for Cancer Research.

14 Aug 2014

Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

The fungal infection invasive aspergillosis (IA) can be life threatening, especially in patients whose immune systems are weakened by chemotherapy or immunosuppressive drugs. Despite the critical need for early detection, IA remains difficult to diagnose.

14 Aug 2014

Scientists identify gene that regulates sleep and wake rhythms

Scientists at the Salk Institute for Biological Studies have identified a gene that regulates sleep and wake rhythms.

14 Aug 2014

Teachers help kids to reduce childhood obesity

An innovative physical activities guide developed at the Frank Porter Graham Child Development Institute (FPG) is helping North Carolina fight childhood obesity.

14 Aug 2014

IUPUI receives $600,000 award from National Science Foundation for drug discoveries

Haibo Ge, Ph.D., assistant professor in the Department of Chemistry and Chemical Biology in the School of Science at Indiana University-Purdue University Indianapolis (IUPUI), is the recipient of a 5-year, $600,000 award from the National Science Foundation (NSF) to fund research that may one day contribute to drug discoveries.

14 Aug 2014

Sound of actual ticking clock can speed up women's attitudes on reproductive timing

The metaphor of a ticking clock is often used to refer to a woman's growing urge - from puberty onwards to menopause - to conceive before her childbearing years are over.

14 Aug 2014

University of Alaska Fairbanks receives $18.8M from NIH for biomedical research

The University of Alaska Fairbanks received an $18.8 million award from the National Institutes of Health to fund statewide biomedical research and student training focused on the interface of health, disease and the environment in people and animals.

14 Aug 2014

Microbiologist receives contract from U.S. DOD to develop vaccine against tularemia

Microbiologist Karl Klose, a professor in the UTSA College of Sciences' Department of Biology and a member of the South Texas Center for Emerging Infectious Diseases, has received a contract from the U.S. Department of Defense (DOD) to conduct research that would bring scholars one step closer to developing a vaccine against tularemia.

14 Aug 2014

Medical Research News

Injections of anaerobic bacteria can shrink tumors in rats, dogs and human

Bacteria in critically ill patients may be growing increasingly resistant to common antiseptic

Cancer Research UK funds projects for new cancer study

More than ½ of emergency department patients age 65 and older are malnourished

Researchers find that nanopores in material MoS2 could sequence DNA more accurately

Recurrence of breast cancer cut by ½ in overweight women who regularly use NSAIDs

Healthy men participating in Prostate Cancer Prevention Trial are most likely to undergo biopsy

Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

Scientists identify gene that regulates sleep and wake rhythms

Teachers help kids to reduce childhood obesity

IUPUI receives $600,000 award from National Science Foundation for drug discoveries

Sound of actual ticking clock can speed up women's attitudes on reproductive timing

University of Alaska Fairbanks receives $18.8M from NIH for biomedical research

Microbiologist receives contract from U.S. DOD to develop vaccine against tularemia

Research and planning to meet health needs of people living with HIV

Health institutions tackle high rate of preterm birth

Researchers examine advantages of being married to physician

New program creates gap between cutting-edge academic research and market uptake

Regular exercise linked with decrease in incidence of breast cancer in African American women

Reducing brain levels of tau protein effectively blocks development of childhood epilepsy

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News